CL — Cresco Labs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Cresco Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	Interim Report	ARS	ARS	ARS
Standards:	IFRS	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	49.1	136	224	119	103
Net Total Accounts Receivable
Net Total Receivables	17.1	32.4	44.7	56.9	52.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	159	249	422	326	278
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	203	301	457	508	486
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	617	1,233	1,780	1,584	1,358
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	150	253	288	281	200
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	429	759	1,025	957	853
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	187	473	756	627	506
Total Liabilities & Shareholders' Equity	617	1,233	1,780	1,584	1,358
Total Common Shares Outstanding